These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 236806)

  • 1. Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.
    Skinner C; Gaddie J; Palmer KN
    Br Med J; 1975 Apr; 2(5962):59-61. PubMed ID: 236806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of labetalol, propranolol and practolol in patients with asthma.
    Larsson K
    Eur J Respir Dis; 1982 May; 63(3):221-30. PubMed ID: 6124442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchoconstrictor effects of beta-adrenergic blockade in asthma: influence of baseline value (author's transl)].
    Gayrard P; Orehek J; Charpin J
    Respiration; 1974 Jan; 31(1):21-37. PubMed ID: 4149265
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
    Prichard BN; Thompson FO; Boakes AJ; Joekes AM
    Clin Sci Mol Med Suppl; 1975 Jun; 2():97s-100s. PubMed ID: 802650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
    Kennedy I; Levy GP
    Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.
    Hicks DC; Phillips EM
    Br J Pharmacol; 1972 Feb; 44(2):377P-378P. PubMed ID: 4148922
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of four beta-adrenoceptor antagonists in patients with asthma.
    Benson MK; Berrill WT; Cruickshank JM; Sterling GS
    Br J Clin Pharmacol; 1978 May; 5(5):415-9. PubMed ID: 26371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
    Weber MA; Drayer JI; Kaufman CA
    J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioselective beta blockade in hypertrophic cardiomyopathy.
    Webb-Peplos MM; Croxson RS; Khanna P; Raphael MJ; Steiner RE; Oakley CM; Goodwin JF
    Acta Cardiol; 1972; ():Suppl 15:263-7. PubMed ID: 4147610
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism.
    Clerici C; Harf A; Macquin-Mavier I
    Br J Pharmacol; 1987 Jul; 91(3):487-92. PubMed ID: 2886173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
    Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.
    Lepäntalo M
    Clin Pharmacol Ther; 1985 Jan; 37(1):7-12. PubMed ID: 3880687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo.
    Pugsley D; Armstrong B; Nassim M; Beilin LJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():501s-503s. PubMed ID: 1071672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.